Page 16 - Heart Failure Clinical Guidelines

16

VII. ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY

A. Initial Evaluation for Patient with Arrhythmogenic Right Ventricular Cardiomyopathy

1. Additional Laboratories, Tests

MRI with contrast (evaluate function, fibrobatty changes)
Laboratories
1. ARVC Genetic Panel
EP Consult

B. Long-Term and Medical Management for Arrhythmogenic Right Ventricular
Cardiomyopathy
To be determined with consultation with electrophysiology consult

1. Sotalol
Indication
-prevention or treatment of ventricular tachycardia

2. Beta Blocker
Indication
-prevention or treatment of ventricular tachycardia

3. Catheter Ablation
Indication
-drug refractory of incessant ventricular tachycardia

4. AICD
Indication
a) syncope or aborted cardiac arrest
b) life threatening arrhythmias uncontrolled by medication
c) family history of cardiac arrest in first degree relative

Treatment of heart failure should follow Section I-B